BOARD OF DIRECTORS

The Company's Board of Directors is comprised of a group of senior executives with broad management and investment experience in both the biotechnology and pharmaceutical industries.

Charles A. Sanders, M.D.
Chairman of the Board of Directors

Anthony B. Evnin, Ph.D.
Venrock Associates

Dennis B. Gillings, Ph.D.
Quintiles Transnational

André L. Lamotte, Sc.D.
HBM BioVentures

Richard G. Morrison, Ph.D.
Eli Lilly

Martin A. Simonetti, M.S., M.B.A.
VLST Corporation

Adeoye Y. Olukotun, M.D., MPH, FACC
VIA Pharmaceuticals

P. Kay Wagoner, Ph.D.
President, Chief Executive Officer and Director, Icagen, Inc.